文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

基于多维度病理生理参数的机械通气急性呼吸窘迫综合征患者亚表型

Subphenotypes of mechanically ventilated acute respiratory distress syndrome patients based on multi-dimensional pathophysiological parameters.
PubMed 文献 · Crit Care · 2025-11-27
一句话结论机械通气ARDS患者可聚类为两种亚表型,亚表型2(PVPI与VR升高)28天死亡率显著更高且对俯卧位通气反应存在差异。

该研究为前瞻性观察性研究的事后分析,推导队列111例机械通气ARDS患者,采用K-means聚类基于肺水肿指标、呼吸力学和气体交换参数识别亚表型,主要终点为28天死亡率。共识别出两种亚表型,亚表型2以肺血管通透性指数(PVPI)和通气比(VR)升高为特征,28天死亡率显著高于亚表型1(50.0% vs 28.2%,p=0.021),多因素Cox回归校正后HR 2.263(95%CI 1.206-4.245;p=0.011)。亚表型与俯卧位通气对28天死亡率存在显著交互作用(交互p=0.015),独立验证队列(n=55)重复了上述亚表型分类及其与临床结局的关系。

要点

  • 机械通气ARDS患者经K-means聚类可分为两种亚表型,亚表型2以PVPI和VR升高为特征。
  • 亚表型2的28天死亡率显著高于亚表型1(50.0% vs 28.2%,p=0.021),校正后HR 2.263(95%CI 1.206-4.245)。
  • 亚表型与俯卧位通气对28天死亡率存在显著交互作用(交互p=0.015),提示两种亚表型对俯卧位的反应不同。
  • 上述亚表型分类及其与结局的关系在独立验证队列(n=55)中一致重复。
  • 作者认为未来需大规模多中心随机对照试验验证上述发现以推进ARDS精准医学。

适用人群与场景

  • 机械通气急性呼吸窘迫综合征患者,推导队列n=111,独立验证队列n=55。

诊断标准与关键阈值

  • 采用K-means聚类,基于肺水肿指标、呼吸力学和气体交换变量识别亚表型;亚表型2以肺血管通透性指数(PVPI)和通气比(VR)升高为特征。

研究设计与关键结果

  • 研究类型为前瞻性观察性研究的事后分析,推导队列n=111,独立验证队列n=55,主要终点为28天死亡率。
  • 聚类识别出两种亚表型,亚表型2(PVPI和VR升高)28天死亡率50.0% vs 亚表型1 28.2%,p=0.021。
  • Kaplan-Meier分析显示亚表型2生存劣势(log-rank p=0.016)。
  • 多因素Cox回归校正协变量后,亚表型2的调整HR 2.263(95%CI 1.206-4.245;p=0.011)。
  • 亚表型与俯卧位通气对28天死亡率存在显著交互作用(交互p=0.015)。
  • 亚表型间预后差异及对俯卧位通气的差异反应在独立验证队列(n=55)中一致重复。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为上述亚表型与临床结局相关且对俯卧位通气反应不同,未来需大规模多中心随机对照试验验证以推进ARDS精准医学的临床实施。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a life-threatening condition with significant heterogeneity in pathophysiology. The integration of pulmonary edema indices, respiratory mechanics, and gas exchange parameters to define subphenotypes in mechanically ventilated patients with ARDS has not yet been investigated.

METHODS: We conducted a post hoc analysis of a prospective observational study with a derivation cohort (n = 111). We applied K-means clustering to identify distinct subphenotypes based on key physiological parameters: pulmonary edema indices, respiratory mechanics, and gas exchange variables. The primary outcome was 28-day mortality. Between-group differences in 28-day mortality were analyzed using the chi-square test. Survival analysis was performed with Kaplan-Meier curves (compared by log-rank test) and multivariable Cox regression to adjust for covariates. Furthermore, we compared the differential responses to prone positioning ventilation among the identified subphenotypes to evaluate its potential interaction effect on mortality. An independent validation cohort (n = 55) was used to confirm the subphenotype classifications and their relationships with clinical outcomes.

RESULTS: Unsupervised clustering revealed two distinct subphenotypes. Subphenotype 2, characterized by elevated pulmonary vascular permeability index (PVPI) and ventilation ratio (VR), demonstrated significantly higher 28-day mortality compared to Subphenotype 1 (50.0% vs. 28.2%, p = 0.021). This survival disadvantage was confirmed by Kaplan-Meier analysis (log-rank p = 0.016) and a multivariable Cox regression model (adjusted hazard ratio [HR] 2.263, 95% confidence interval [CI] 1.206-4.245; p = 0.011). Furthermore, a statistically significant interaction was observed between subphenotypes and response to prone positioning for 28-day mortality (p-for-interaction = 0.015). Crucially, the prognostic distinction between subphenotypes and their differential treatment response were consistently replicated in an independent validation cohort.

CONCLUSIONS: Using unsupervised machine learning, this study identified two distinct ARDS subphenotypes characterized by divergent profiles in pulmonary edema, respiratory mechanics, and gas exchange. These subphenotypes were associated with significantly different clinical outcomes and exhibited a differential response to prone positioning therapy. Future research should prioritize the execution of large-scale, multicenter, randomized controlled trials to validate these findings and advance the clinical implementation of precision medicine in the management of ARDS.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Li L, Huang X, Luo W, et al. Subphenotypes of mechanically ventilated acute respiratory distress syndrome patients based on multi-dimensional pathophysiological parameters. Crit Care. 2025. PMID: 41310764. doi:10.1186/s13054-025-05768-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。